In the ever-evolving pharmaceutical industry, the global market for Ursodiol is witnessing remarkable growth, driven by increasing prevalence of gallstone diseases, primary biliary cholangitis (PBC), and rising awareness of liver health. As a crucial bile acid used in the treatment of liver-related disorders, Ursodiol is gaining traction worldwide.
According to Statifacts, the global ursodiol market size was valued at USD 507 million in 2024 and is predicted to gain around USD 1,466 million by 2034, exhibiting a robust CAGR of 11.2% from 2025 to 2034. The expansion is fueled by advancements in pharmaceutical formulations, increased research activities, and growing demand for effective therapies targeting hepatobiliary disorders.
read more..